ABSTRACT
Este trabalho está baseado na Recomendação Provisória (1), revista de modo a levar em conta os comentários recebidos, e foi aceito pelo Conselho da Federação Internacional de Química Clínica (IFCC) em votação procedida em 1985. Este trabalho constitui parte de uma série de recomendações sobre medições de concentrações catalíticas de enzimas. As demais referem -se ao seguinte: Parte 1. Condições gerais (2) Parte 2. Método para Aspartato Aminotransferase (3) Parte 4. Método para δ glutamiltransferase (4) Parte 5. Método para Fosfatase Alcalina (5) Parte 6. Materiais de Referência para medição de Enzimas Parte 7. Método para Creatina Quinase.
Subject(s)
Spectrophotometry/instrumentation , Alkaline Phosphatase/analysisSubject(s)
Alanine Transaminase/blood , Alanine/metabolism , Drug Stability , Humans , Hydrogen-Ion Concentration , Ketoglutaric Acids/metabolism , L-Lactate Dehydrogenase/metabolism , Mathematics , Methods , Pyridoxal Phosphate/pharmacology , Specimen Handling , Spectrophotometry, Ultraviolet , Time FactorsABSTRACT
Conditions for accurate measurement of catalytic activity of aspartate aminotransferase and alanine aminotransferase in human serum have been reinvestigated. The basic variables (kind of buffer, buffer concentration, pH, ion effects, and the influence of pyridoxal-5-phosphate) can now be considered optimized. On this basis, the kinetic parameters of both aminotransferases were determined, i.e., Michaelis and inhibitor constants for substrates and reaction products. With a mathematical approach for two-substrate enzyme reactions the substrate concentrations were calculated from the viewpoints "most economical," "most convenient," and "lowest variability." Also the conditions for the indicator reactions have been newly defined with respect to a kinetic model. All calculated data were rechecked experimentally and it can be shown that both approaches fully agree. Furthermore, we show that the mathematical approach allows more precise recommendations for optimized methods. For technical reasons, the catalytic activity of aspartate aminotransferase in human serum can only be measured as a 0.96 fraction of its theoretical maximum velocity, the catalytic activity of alanine aminotransferase as a 0.91 fraction. The assay conditions for a Reference Method are finally described and recommendations are made for optimized routine methods for determination of the catalytic activity of these transferases in human serum.
Subject(s)
Alanine Transaminase/blood , Aspartate Aminotransferases , Aspartate Aminotransferases/blood , Alanine Transaminase/antagonists & inhibitors , Anions , Aspartate Aminotransferases/antagonists & inhibitors , Glutamates , Heart Diseases/enzymology , Humans , Hydrogen-Ion Concentration , Ketoglutaric Acids , Kinetics , Liver Diseases/enzymology , Mathematics , Methods , Osmolar Concentration , Pyridoxal Phosphate/pharmacology , PyruvatesABSTRACT
A modern approach is described for the evaluation of the optimal conditions for two-substrate enzyme reactions. It chiefly involves the determination of the concentration of substrates for the primary reaction and the catalytic concentration of indicator enzymes. The interrelationship between the concentration of the two substrates (concentration pairs) are described mathematically to be hyperbolic, and, in case of competitively inhibited reactions, to be parabolic. Calculated optimum concentrations have been rechecked experimentally for the reactions of aspartate aminotransferase and alanine aminotransferase. For pyridine coenzyme linked indicator reactions it could be demonstrated that they mostly follow zero order kinetics. One of the products of the primary reaction reacts, in its steady state concentration, as the second substrate. This represents the size of the lag phase of the coupled reaction. The Km of this substance must be known in order to calculate the catalytic concentration of the indicator enzyme in relation to that of the primary enzyme. Its concentration can be fixed arbitrarily within certain limits, depending on whether the calculated result actually can be realized; otherwise a larger lag phase must be tolerated. For practical reasons, it is generally possible to measure only a certain percentage of maximum reaction rate.
Subject(s)
Alanine Transaminase/metabolism , Aspartate Aminotransferases/metabolism , Kinetics , Binding Sites , Mathematics , Methods , Protein BindingSubject(s)
Chemistry, Clinical , NADP , NAD , Chemistry, Clinical/methods , Hydrogen-Ion Concentration , Osmolar Concentration , TemperatureSubject(s)
Aspartate Aminotransferases/blood , Evaluation Studies as Topic , Humans , Mathematics , Methods , Pharmacology , Quality ControlABSTRACT
Km is necessary to calculate the conditions for indicator reactions in coupled enzymic assays. When malate dehydrogenase is used as an indicator enzyme for the assay of aspartate aminotransferase activity, its Km in relation to oxaloacetate is needed. Km (oxaloacetate) of commercially available mitochondrial malate dehydrogenase from pig heart was determined as Km equals 1.65 x 10(-5) mol/1 using the measurement conditions for aspartate aminotransferase according to the preliminary recommendations of the IFCC.
Subject(s)
Aspartate Aminotransferases/metabolism , Malate Dehydrogenase/metabolism , Myocardium/enzymology , Animals , Mitochondria, Muscle/enzymology , Oxaloacetates , SwineABSTRACT
Extensive re-investigations with regard to the molar extinction coefficients of NADH and NADPH proved that in future, calculations in routine work can be performed with the following much more accurate epsilon-values: 6.15 x 10(3) 1 x mol-1 x cm-1 at Hg 334 nm (NADH and NADPH), 6.3 X 10(3) 1 X mol-1 x cm-1 at 340 nm (NADH and NADPH), 3.4 X 10(3) 1 X mol-1 X Cm-1 (NADH) and 3.5 x 10(3) 1 x mol-1 x cm-1 (NADPH) at Hg 365 nm, respectively. The safest measurement is performed at Hg 334 nm, because here epsilon is identical for both coenzymes and deviations of the epsilon-value caused by temperature, pH and ionic strength are less than 0.5%.